152 related articles for article (PubMed ID: 21570793)
1. Fusion of dynamic contrast-enhanced magnetic resonance mammography at 3.0T with X-ray mammograms: pilot study evaluation using dedicated semi-automatic registration software.
Dietzel M; Hopp T; Ruiter N; Zoubi R; Runnebaum IB; Kaiser WA; Baltzer PA
Eur J Radiol; 2011 Aug; 79(2):e98-e102. PubMed ID: 21570793
[TBL] [Abstract][Full Text] [Related]
2. A complete software application for automatic registration of x-ray mammography and magnetic resonance images.
Solves-Llorens JA; Rupérez MJ; Monserrat C; Feliu E; García M; Lloret M
Med Phys; 2014 Aug; 41(8):081903. PubMed ID: 25086534
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of free-form deformation registration for dynamic contrast-enhanced MR mammography.
Tanner C; Schnabel JA; Hill DL; Hawkes DJ; Degenhard A; Leach MO; Hose DR; Hall-Craggs MA; Usiskin SI
Med Phys; 2007 Apr; 34(4):1221-33. PubMed ID: 17500454
[TBL] [Abstract][Full Text] [Related]
4. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
[TBL] [Abstract][Full Text] [Related]
5. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
6. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
7. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
8. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
[TBL] [Abstract][Full Text] [Related]
9. Breast lesion co-localisation between X-ray and MR images using finite element modelling.
Lee AW; Rajagopal V; Babarenda Gamage TP; Doyle AJ; Nielsen PM; Nash MP
Med Image Anal; 2013 Dec; 17(8):1256-64. PubMed ID: 23860392
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
11. Automatic multimodal 2D/3D breast image registration using biomechanical FEM models and intensity-based optimization.
Hopp T; Dietzel M; Baltzer PA; Kreisel P; Kaiser WA; Gemmeke H; Ruiter NV
Med Image Anal; 2013 Feb; 17(2):209-18. PubMed ID: 23265802
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of controlled aliasing in parallel imaging results in a higher acceleration (CAIPIRINHA)-volumetric interpolated breathhold (VIBE) sequence for gadoxetic acid-enhanced liver MR imaging.
Yu MH; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
J Magn Reson Imaging; 2013 Nov; 38(5):1020-6. PubMed ID: 23559147
[TBL] [Abstract][Full Text] [Related]
13. [New trends and novel possibilities in the diagnostic imaging of breast cancer].
Bidlek M; Kovács E; Fehér K; Gõdény M
Magy Onkol; 2015 Mar; 59(1):44-55. PubMed ID: 25763913
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
17. MRI to X-ray mammography registration using a volume-preserving affine transformation.
Mertzanidou T; Hipwell J; Cardoso MJ; Zhang X; Tanner C; Ourselin S; Bick U; Huisman H; Karssemeijer N; Hawkes D
Med Image Anal; 2012 Jul; 16(5):966-75. PubMed ID: 22513136
[TBL] [Abstract][Full Text] [Related]
18. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
19. Fusion of contrast-enhanced breast MR and mammographic imaging data.
Behrenbruch CP; Marias K; Armitage PA; Yam M; Moore N; English RE; Clarke J; Brady M
Med Image Anal; 2003 Sep; 7(3):311-40. PubMed ID: 12946471
[TBL] [Abstract][Full Text] [Related]
20. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
